AURORA, Colo. (Jan. 4, 2010) – Two University of Colorado’s School of Pharmacy researchers have been named American Association for the Advancement of Science (AAAS) Pharmaceutical Sciences fellows and a third has been elected as a fellow of the Association for Research in Vision and Ophthalmology (ARVO). Raj Agarwal, PhD, and John Carpenter, PhD, are two of only eight Pharmaceutical Sciences AAAS fellows elected in 2009. Uday Kompella, PhD, will be awarded ARVO fellow status in 2010.
According to AAAS, a fellow is defined as a member whose efforts in the advancement of science or its applications are scientifically or socially distinguished. Agarwal and Carpenter were nominated by their peers for their work in pharmaceutical sciences.
“This is a great honor, and I want to thank all my peers who nominated and supported me,” said Agarwal.
In Nov. 2009, the AAAS Council elected 531 members as Fellows of AAAS. Out of the 531, five are from the University of Colorado (three from CU-Boulder and two from CU Denver’s School of Pharmacy). These individuals will be recognized for their contributions to science and technology at the Fellows Forum on Feb. 20, 2010, during the AAAS Annual Meeting in San Diego.
Fellow nominations may be made by the Steering Groups of the Association’s 24 sections, or by any three fellows who are current AAAS members, so long as two of the three sponsors are not affiliated with the nominee’s institution, or by the Chief Executive Officer.
Nominations undergo review by the Steering Groups of the Association’s sections (the Chair, Chair-Elect, Retiring Chair, Secretary, and four Members-at-Large of each section). Each Steering Group reviews only those nominations designated for its section. Names of Fellow nominees who are approved by the Steering Groups are presented to the AAAS Council for election.
For a list of fellows elected in 2009, please visit: http://www.aaas.org/news/releases/2009/1218fellows.shtml.
ARVO is an international organization that attracts the world’s leading experts in ophthalmic research. The purpose of ARVO is to encourage and assist research, training, publication, and dissemination of knowledge in vision and ophthalmology. The title of ARVO fellow is an honor established to recognize current ARVO members for their individual accomplishments, leadership and contributions to the Association.
“All my research work related to the eye is typically presented first at the ARVO annual meetings, and input from ARVO members over the years has been extremely helpful in shaping my research and career,” said Kompella. “I am delighted that I have been selected to receive the ARVO fellow designation.”
Eligibility for the fellow designation is determined by a point system established by the ARVO board by which members earn points for various types of service to ARVO and participation in ARVO-sponsored activities.
Kompella, along with 251 others, will be honored at the 2010 annual meeting of ARVO in Fort Lauderdale, Fla., in May.
For a list of 2010 ARVO fellows, please visit: http://www.arvo.org/EWEB/dynamicpage.aspx?site=arvo2&webcode=arvofellows2010.
About University of Colorado Denver
The University of Colorado Denver is located in Denver on the Downtown Campus and on the Anschutz Medical Campus in Aurora, Colo. CU Denver offers more than 120 degrees and programs in 13 schools and colleges and serves more than 28,000 students. For more information, visit the CU Denver Newsroom.
The American Association for the Advancement of Science (AAAS) is an international non-profit organization dedicated to advancing science around the world by serving as an educator, leader, spokesperson and professional association. Founded in 1848, AAAS publishes the journal, Science (www.sciencemag.org), and serves some 262 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS (www.aaas.org) is open to all and fulfills its mission to “advance science and serve society” through initiatives in science policy; international programs; science education; and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS.
The Association for Research in Vision and Ophthalmology, Inc. (ARVO) was founded in 1928 in Washington, DC by 73 ophthalmologists. ARVO was originally named the Association for Research in Ophthalmology (ARO), but the word “vision” was added in 1970 to better reflect the scientific profile of its members. The Association’s membership, comprised of more than 12,500 individuals, continues to grow. Some 42% of members reside in over 70 countries outside the U.S. The membership is multidisciplinary and consists of both clinical and basic researchers (approximately 44% MD/Ophthalmologists, 26% PhD’s, and 30% Other, including optometrists, osteopaths, and veterinarians). In 1986, ARVO established its first permanent office located on the campus of the Federation of American Societies for Experimental Biology (FASEB), in Bethesda, Maryland. In 2001 the ARVO Office relocated to Rockville, Maryland.
Contact: Caitlin Jenney, 303.315.6376, email@example.com